BSETyche Industries Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 5 Sept, 2025 · 17:35 IST

27th Annual Report of the Company for the Financial Year 2024-25.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.8%Reaction day
₹137.95
prior close
₹135.25
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.2% vs market
Pharmaceuticals peers, median of 151sector+0.0%-1.8% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.9
10m
+2.9
15m
+2.9
30m
+2.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.8+0.4-2.2+0.0-1.8
Next day
-1.4+0.6-2.0+0.1-1.5
2d
-1.6+1.0-2.6+0.0-1.6
3d
-1.1+0.9-2.0+0.3-1.3
4d
+1.7+0.9+0.8+0.7+1.0
5d
+0.8+1.6-0.9+0.6+0.2
1w
+4.3+2.8+1.4+1.0+3.3
15d
-0.9-2.5+1.6-3.3+2.4
1m
+1.5-1.0+2.5-2.7+4.2
2m
-4.4-0.4-4.0-4.7+0.3
3m
-16.7-7.0-9.7-7.6-9.1
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Tyche Industries has submitted its 27th Annual Report for FY 2024-25 along with the notice for the 27th Annual General Meeting, to be held on September 30, 2025 via video conferencing. The Board has recommended a dividend of Rs. 3.00 per equity share (30%) on shares of Rs. 10 face value, subject to shareholder approval. Key board changes include the appointment of Mr. Sandeep Gokaraju as Managing Director for 5 years from September 5, 2025, Mr. Satya Srinivas Uppalapati as Executive Director (Promoter category), and re-appointment of Mrs. Penumatsa Vijaya Lakshmi as Independent Director for another 5-year term. Mr. G. Ganesh Kumar's designation has changed from Chairman & Managing Director to Executive Director. The company has a registered office in Hyderabad, Telangana and a factory in Kakinada, Andhra Pradesh.

Likely market impact

Shareholders stand to receive a Rs. 3 per share dividend (record date September 19, 2025), indicating reasonable profitability for FY25. The leadership restructuring, including elevation of Sandeep Gokaraju to MD, signals a generational or succession transition within the promoter family that investors should monitor closely.